Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
111 Leser
Artikel bewerten:
(0)

Research and Markets - Aesthetic Market in US to Grow at a CAGR of 8% by 2021 - Key Vendors are Allergan, Cynosure, Galderma, Merz Pharma, Sientra & Valeant Pharmaceuticals

DUBLIN, May 29, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Aesthetic Market in US 2017-2021" report to their offering.

Logo

The aesthetic market in US market to grow at a CAGR of 8.09% during the period 2017-2021.

This report, Aesthetic Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is emergence of combination treatments. The combination of various plastic or cosmetic surgeries has become a new trend in the aesthetic market. Surgeons have started adopting a combination of surgical and non-surgical ocedures to ovide more comehensive results.

According to the report, one of the major drivers for this market is shift from invasive to minimally invasive and non-invasive ocedures. Minimally invasive and non-invasive ocedures are techniques that limit the size of incisions and therefore lowers pain and scarring, enable speedy recovery, and reduce the incidence of post-surgical complications such as adhesions and wound dehiscence.


Further, the report states that one of the major factors hindering the growth of this market is high cost. The adoption rate of aesthetics oducts is low in the middle-income group due to the high cost. For instance, the ice for dermal fillers ranges from $400 to $1,500. The average ice of dermal facial fillers is apoximately $950. Moreover, the cost of the treatments is high because of the monopolistic nature of the market. For instance, ALLERGAN has acquired most of the market for facial aesthetics. Thus, the market lacks competitive icing. Further, most vendors target their oducts for the high-income and upper-middle-class patients.

Key vendors:

  • Allergan
  • Cynosure
  • Galderma
  • Merz Pharma
  • Sientra
  • Valeant Pharmaceuticals

Other prominent vendors:

  • Alma Lasers
  • AQTIS Medical
  • AART
  • Andrew Technologies
  • Body BeneFits
  • BTL Industries
  • Deka Laser Technologies
  • Erchonia
  • Others

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Product segmentation

Part 07: End-user segmentation

Part 08: Decision framework

Part 09: Drivers and challenges

Part 10: Market trends

Part 11: Vendor landscape

Part 12: Key vendor analysis

For more information about this report visit http://www.researchandmarkets.com/research/kh4rtd/aesthetic_market

Media Contact:


Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.